Chloride salt of TAT-NR2B9c
AssigneeNoNO Inc.
InventorJonathan David Garman
Life of this patent
Estimating the term…
Abstract
The present invention provides lyophilized formulations of active agents, particularly of TAT-NR2B9c, as chloride salts. TAT-NR2B9c has shown promise for treating stroke, aneurysm, subarachnoid hemorrhage and other neurological or neurotraumatic conditions. The chloride salt of TAT-NR2B9c shows improved stability compared with the acetate salt form of prior formulations. Formulations of the chloride salt of TAT-NR2B9c are stable at ambient temperature thus facilitating maintenance of supplies of such a formulation in ambulances for administration at the scene of illness or accident or in transit to a hospital.
Claims34
A chloride salt of a peptide which is TAT-NR2B9c (SEQ ID NO:6) or differs from TAT-NR2B9c by up to 5 amino acid substitutions, insertions or deletions, wherein greater than 99% of anions in the salt are chloride.
A reconstituted formulation comprising a chloride salt of TAT-NR2B9c at a concentration of 15-25 mg/ml, a buffer and a sugar.
Dependencies are inferred from the claim text.